Kenya’s MYDAWA Secures Funding to Scale E-Pharmacy Model
TLDR
- Kenyan e-health platform MYDAWA has raised an undisclosed amount in a new funding round aimed at expanding its technology-driven healthcare model across Africa
- The round included participation from IFU (Denmark’s investment fund for developing countries), Alta Semper Capital, AAIC Investment, Creadev, and Japan’s Ohara Pharmaceutical Co
- The capital will also support expanded chronic disease care and new market entry
Kenyan e-health platform MYDAWA has raised an undisclosed amount in a new funding round aimed at expanding its technology-driven healthcare model across Africa. The round included participation from IFU (Denmark’s investment fund for developing countries), Alta Semper Capital, AAIC Investment, Creadev, and Japan’s Ohara Pharmaceutical Co.
Founded in 2017, MYDAWA offers an integrated digital health platform combining virtual consultations, lab testing, chronic care management, e-prescriptions, and last-mile medication delivery. Operating in Kenya and Uganda, the startup plans to scale its “Bricks-and-Clicks Super Pharmacy” model and introduce AI-driven tools to optimize inventory, improve service efficiency, and lower patient costs.
Founder Neil O’Leary said the investor lineup underscores market confidence in MYDAWA’s vision and scalability. Alta Semper partner Zach Fond called MYDAWA a “category leader” in digital health across Africa. The capital will also support expanded chronic disease care and new market entry.
Daba is Africa's leading investment platform for private and public markets. Download here
Key Takeaways
MYDAWA’s funding reflects a broader push to digitize healthcare delivery in Africa, where access gaps remain widespread. Its hybrid model combines physical infrastructure with digital channels, making it suitable for managing chronic diseases, streamlining diagnostics, and improving pharmaceutical distribution. The company’s platform addresses common bottlenecks in African health systems: long wait times, limited specialist access, fragmented diagnostics, and high out-of-pocket medication costs. By integrating AI tools, MYDAWA aims to reduce inefficiencies across the care continuum. Its backers, which include healthcare and impact-focused investors, view the company as a blueprint for tech-enabled health access at scale. MYDAWA’s entry into Uganda marks early regional expansion, with more markets likely to follow. As health systems across Africa prioritize tech-driven solutions post-pandemic, MYDAWA is positioning itself at the intersection of healthtech, e-commerce, and pharmaceutical logistics—an emerging category set to transform how care is delivered to underserved populations.
Think someone else should see this?
To invest in this opportunity and other opportunities across Africa
Download the daba finance app on your mobile through
Take action.
Download app
Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.
Partner with us
Unlock exciting business opportunities and growth potential.
Join Daba
Become a part of our vibrant community and enjoy exclusive benefits.
Contact us
Reach out to us for inquiries, support, or collaboration.